Biotechnology Value Fund L P's Form 4 filing
Eledon Pharmaceuticals, Inc. (ELDN) · filed May 13, 2024
- Accession no.
- 0000921895-24-001131
- Filed
- May 13, 2024, 5:04 PM ET
- Trade date
- May 9, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 3 derivative transactions. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Biotechnology Value Fund L PCIK 0000918923 | Other: See Explanation of Responses |
| BVF Partners L PCIK 0001055947 | 10% Owner |
| BVF IncCIK 0001056807 | 10% Owner |
| Biotechnology Value Fund II LPCIK 0001102444 | Other: See Explanation of Responses |
| Lampert Mark NCIK 0001233840 | 10% Owner |
| Biotechnology Value Trading Fund OS LPCIK 0001660683 | Other: See Explanation of Responses |
| BVF Partners OS Ltd.CIK 0001660684 | Other: See Explanation of Responses |
| BVF I GP LLCCIK 0001803805 | Other: See Explanation of Responses |
| BVF II GP LLCCIK 0001803806 | Other: See Explanation of Responses |
| BVF GP Holdings LLCCIK 0001803809 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 9, 2024 | Common Stock, $0.001 par value | PPurchaseAcquired | +1,031,385 | – | – | 3,361,803 | Direct | |
| May 9, 2024 | Common Stock, $0.001 par value | PPurchaseAcquired | +821,121 | – | – | 2,633,679 | Direct | |
| May 9, 2024 | Common Stock, $0.001 par value | PPurchaseAcquired | +75,431 | – | – | 220,460 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 9, 2024 | Common Stock, $0.001 par value | PPurchaseAcquired | +3,173,135 | – | – | 3,173,135 | Direct | |
| May 9, 2024 | Common Stock, $0.001 par value | PPurchaseAcquired | +2,526,238 | – | – | 2,526,238 | Direct | |
| May 9, 2024 | Common Stock, $0.001 par value | PPurchaseAcquired | +232,068 | – | – | 232,068 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.